Suppr超能文献

103例先天性甲状腺功能减退症患儿在甲状腺激素替代治疗前及治疗期间的头围、身高、骨龄和体重。

Head circumference, height, bone age and weight in 103 children with congenital hypothyroidism before and during thyroid hormone replacement.

作者信息

Bucher H, Prader A, Illig R

出版信息

Helv Paediatr Acta. 1985 Sep;40(4):305-16.

PMID:4077564
Abstract

Head circumference, height, bone age and weight were studied in 103 children with congenital hypothyroidism before and up to 8 years of thyroid replacement therapy. The patients were divided into 4 groups according to the age at start of treatment: group I (diagnosed by neonatal screening): less than 2 weeks (n = 55); group II: 1-3 months (n = 7); group III: 4-12 months (n = 15); group IV: greater than 1 year of age (n = 26). Before treatment, group I showed a head circumference significantly larger than normal and a delay in bone maturation in the presence of normal length and weight. In the other groups length as well as bone age were significantly lower than normal, head circumference, in contrast, was normal (groups II and III) or even increased (group IV). During therapy, head circumference and bone age of group I became normal as were length and weight from the beginning. In the other groups, therapy led to a further increase of head size resulting in a mean head circumference significantly larger than normal during 8 years of observation in group IV. There was a catch-up of height, bone age and weight in groups II, III and IV; mean height of late treated children (group IV), however, remained significantly lower than normal even after 8 years of therapy. - Our study shows that congenital hypothyroidism is associated with increased head circumference, either absolutely or in relation to stature. Thyroid hormone therapy resulted in a normalization of head growth when treatment was initiated early, and in a further increase when treatment was started late. There was a catch-up of height, bone age and weight; complete normalization, however, occurred only in those children treated before one year of age.

摘要

对103例先天性甲状腺功能减退症患儿在甲状腺替代治疗前及治疗长达8年期间的头围、身高、骨龄和体重进行了研究。根据开始治疗时的年龄将患者分为4组:I组(通过新生儿筛查诊断):小于2周(n = 55);II组:1 - 3个月(n = 7);III组:4 - 12个月(n = 15);IV组:大于1岁(n = 26)。治疗前,I组头围明显大于正常,在身长和体重正常的情况下骨成熟延迟。在其他组中,身长和骨龄明显低于正常,相比之下,头围正常(II组和III组)或甚至增加(IV组)。治疗期间,I组的头围和骨龄恢复正常,身长和体重从一开始就正常。在其他组中,治疗导致头围进一步增大,在IV组8年的观察期内平均头围明显大于正常。II组、III组和IV组的身高、骨龄和体重出现追赶生长;然而,即使经过8年治疗,治疗较晚的儿童(IV组)的平均身高仍明显低于正常。——我们的研究表明,先天性甲状腺功能减退症与头围增大有关,无论是绝对增大还是相对于身高增大。早期开始治疗时,甲状腺激素治疗可使头围生长恢复正常,而晚期开始治疗时则会使头围进一步增大。身高、骨龄和体重出现追赶生长;然而,只有在1岁前接受治疗的儿童中才会完全恢复正常。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验